Cefuroxime treatment of bacterial meningitis in infants and children

Insights

Cefuroxime effectively treated meningitis caused by drug-resistant Haemophilus influenzae type b and Salmonella strains in children. This antibiotic shows promise as an alternative therapy for these serious infections.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Pediatrics

Background:

  • Emergence of ampicillin- and chloramphenicol-resistant Haemophilus influenzae type b and multiply-resistant Salmonella strains necessitates alternative treatments.
  • Bacterial meningitis remains a significant global health concern, particularly in pediatric populations.

Purpose of the Study:

  • To evaluate the efficacy and safety of cefuroxime in treating pediatric meningitis caused by antibiotic-resistant bacteria.
  • To determine cefuroxime concentrations in cerebrospinal fluid and subdural fluid during treatment.

Main Methods:

  • Clinical case series involving seven children diagnosed with meningitis.
  • Treatment with cefuroxime at 200-250 mg/kg/day in four divided doses for 14-21 days.
  • Measurement of cefuroxime levels in cerebrospinal fluid and subdural fluid.

Main Results:

  • Successful treatment outcomes were observed in all five children with H. influenzae type b meningitis and two children with Salmonella meningitis.
  • Cefuroxime achieved therapeutic concentrations in cerebrospinal fluid, exceeding levels in non-meningitis patients.
  • Adequate cefuroxime concentrations were also found in subdural fluid samples.

Conclusions:

  • Cefuroxime is a recommended alternative therapy for meningitis caused by H. influenzae type b, especially resistant strains.
  • Further research is needed to establish cefuroxime's role in treating Salmonella meningitis.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...